CKR-49-17 is an activator of CK1gamma2. CKR-49-17 decreases C99 and beta-amyloid levels. CKR-49-17 can be used in the research of Alzheimers disease (AD)[1].
Molecular Weight:
391.49
Purity:
98.40
Formula:
C21H21N5OS
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted